<!DOCTYPE html><html>

<head>
<meta charset="utf-8">
<title>index</title>
<style type="text/css">
body {
  font-family: Helvetica, arial, sans-serif;
  font-size: 14px;
  line-height: 1.6;
  padding-top: 10px;
  padding-bottom: 10px;
  background-color: white;
  padding: 30px; }

body > *:first-child {
  margin-top: 0 !important; }
body > *:last-child {
  margin-bottom: 0 !important; }

a {
  color: #4183C4; }
a.absent {
  color: #cc0000; }
a.anchor {
  display: block;
  padding-left: 30px;
  margin-left: -30px;
  cursor: pointer;
  position: absolute;
  top: 0;
  left: 0;
  bottom: 0; }

h1, h2, h3, h4, h5, h6 {
  margin: 20px 0 10px;
  padding: 0;
  font-weight: bold;
  -webkit-font-smoothing: antialiased;
  cursor: text;
  position: relative; }

h1:hover a.anchor, h2:hover a.anchor, h3:hover a.anchor, h4:hover a.anchor, h5:hover a.anchor, h6:hover a.anchor {
  background: url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABAAAAAQCAYAAAAf8/9hAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAA09pVFh0WE1MOmNvbS5hZG9iZS54bXAAAAAAADw/eHBhY2tldCBiZWdpbj0i77u/IiBpZD0iVzVNME1wQ2VoaUh6cmVTek5UY3prYzlkIj8+IDx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iIHg6eG1wdGs9IkFkb2JlIFhNUCBDb3JlIDUuMy1jMDExIDY2LjE0NTY2MSwgMjAxMi8wMi8wNi0xNDo1NjoyNyAgICAgICAgIj4gPHJkZjpSREYgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj4gPHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9IiIgeG1sbnM6eG1wPSJodHRwOi8vbnMuYWRvYmUuY29tL3hhcC8xLjAvIiB4bWxuczp4bXBNTT0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wL21tLyIgeG1sbnM6c3RSZWY9Imh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC9zVHlwZS9SZXNvdXJjZVJlZiMiIHhtcDpDcmVhdG9yVG9vbD0iQWRvYmUgUGhvdG9zaG9wIENTNiAoMTMuMCAyMDEyMDMwNS5tLjQxNSAyMDEyLzAzLzA1OjIxOjAwOjAwKSAgKE1hY2ludG9zaCkiIHhtcE1NOkluc3RhbmNlSUQ9InhtcC5paWQ6OUM2NjlDQjI4ODBGMTFFMTg1ODlEODNERDJBRjUwQTQiIHhtcE1NOkRvY3VtZW50SUQ9InhtcC5kaWQ6OUM2NjlDQjM4ODBGMTFFMTg1ODlEODNERDJBRjUwQTQiPiA8eG1wTU06RGVyaXZlZEZyb20gc3RSZWY6aW5zdGFuY2VJRD0ieG1wLmlpZDo5QzY2OUNCMDg4MEYxMUUxODU4OUQ4M0REMkFGNTBBNCIgc3RSZWY6ZG9jdW1lbnRJRD0ieG1wLmRpZDo5QzY2OUNCMTg4MEYxMUUxODU4OUQ4M0REMkFGNTBBNCIvPiA8L3JkZjpEZXNjcmlwdGlvbj4gPC9yZGY6UkRGPiA8L3g6eG1wbWV0YT4gPD94cGFja2V0IGVuZD0iciI/PsQhXeAAAABfSURBVHjaYvz//z8DJYCRUgMYQAbAMBQIAvEqkBQWXI6sHqwHiwG70TTBxGaiWwjCTGgOUgJiF1J8wMRAIUA34B4Q76HUBelAfJYSA0CuMIEaRP8wGIkGMA54bgQIMACAmkXJi0hKJQAAAABJRU5ErkJggg==) no-repeat 10px center;
  text-decoration: none; }

h1 tt, h1 code {
  font-size: inherit; }

h2 tt, h2 code {
  font-size: inherit; }

h3 tt, h3 code {
  font-size: inherit; }

h4 tt, h4 code {
  font-size: inherit; }

h5 tt, h5 code {
  font-size: inherit; }

h6 tt, h6 code {
  font-size: inherit; }

h1 {
  font-size: 28px;
  color: black; }

h2 {
  font-size: 24px;
  border-bottom: 1px solid #cccccc;
  color: black; }

h3 {
  font-size: 18px; }

h4 {
  font-size: 16px; }

h5 {
  font-size: 14px; }

h6 {
  color: #777777;
  font-size: 14px; }

p, blockquote, ul, ol, dl, li, table, pre {
  margin: 15px 0; }

hr {
  background: transparent url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAYAAAAECAYAAACtBE5DAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAAyJpVFh0WE1MOmNvbS5hZG9iZS54bXAAAAAAADw/eHBhY2tldCBiZWdpbj0i77u/IiBpZD0iVzVNME1wQ2VoaUh6cmVTek5UY3prYzlkIj8+IDx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iIHg6eG1wdGs9IkFkb2JlIFhNUCBDb3JlIDUuMC1jMDYwIDYxLjEzNDc3NywgMjAxMC8wMi8xMi0xNzozMjowMCAgICAgICAgIj4gPHJkZjpSREYgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj4gPHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9IiIgeG1sbnM6eG1wPSJodHRwOi8vbnMuYWRvYmUuY29tL3hhcC8xLjAvIiB4bWxuczp4bXBNTT0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wL21tLyIgeG1sbnM6c3RSZWY9Imh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC9zVHlwZS9SZXNvdXJjZVJlZiMiIHhtcDpDcmVhdG9yVG9vbD0iQWRvYmUgUGhvdG9zaG9wIENTNSBNYWNpbnRvc2giIHhtcE1NOkluc3RhbmNlSUQ9InhtcC5paWQ6OENDRjNBN0E2NTZBMTFFMEI3QjRBODM4NzJDMjlGNDgiIHhtcE1NOkRvY3VtZW50SUQ9InhtcC5kaWQ6OENDRjNBN0I2NTZBMTFFMEI3QjRBODM4NzJDMjlGNDgiPiA8eG1wTU06RGVyaXZlZEZyb20gc3RSZWY6aW5zdGFuY2VJRD0ieG1wLmlpZDo4Q0NGM0E3ODY1NkExMUUwQjdCNEE4Mzg3MkMyOUY0OCIgc3RSZWY6ZG9jdW1lbnRJRD0ieG1wLmRpZDo4Q0NGM0E3OTY1NkExMUUwQjdCNEE4Mzg3MkMyOUY0OCIvPiA8L3JkZjpEZXNjcmlwdGlvbj4gPC9yZGY6UkRGPiA8L3g6eG1wbWV0YT4gPD94cGFja2V0IGVuZD0iciI/PqqezsUAAAAfSURBVHjaYmRABcYwBiM2QSA4y4hNEKYDQxAEAAIMAHNGAzhkPOlYAAAAAElFTkSuQmCC) repeat-x 0 0;
  border: 0 none;
  color: #cccccc;
  height: 4px;
  padding: 0;
}

body > h2:first-child {
  margin-top: 0;
  padding-top: 0; }
body > h1:first-child {
  margin-top: 0;
  padding-top: 0; }
  body > h1:first-child + h2 {
    margin-top: 0;
    padding-top: 0; }
body > h3:first-child, body > h4:first-child, body > h5:first-child, body > h6:first-child {
  margin-top: 0;
  padding-top: 0; }

a:first-child h1, a:first-child h2, a:first-child h3, a:first-child h4, a:first-child h5, a:first-child h6 {
  margin-top: 0;
  padding-top: 0; }

h1 p, h2 p, h3 p, h4 p, h5 p, h6 p {
  margin-top: 0; }

li p.first {
  display: inline-block; }
li {
  margin: 0; }
ul, ol {
  padding-left: 30px; }

ul :first-child, ol :first-child {
  margin-top: 0; }

dl {
  padding: 0; }
  dl dt {
    font-size: 14px;
    font-weight: bold;
    font-style: italic;
    padding: 0;
    margin: 15px 0 5px; }
    dl dt:first-child {
      padding: 0; }
    dl dt > :first-child {
      margin-top: 0; }
    dl dt > :last-child {
      margin-bottom: 0; }
  dl dd {
    margin: 0 0 15px;
    padding: 0 15px; }
    dl dd > :first-child {
      margin-top: 0; }
    dl dd > :last-child {
      margin-bottom: 0; }

blockquote {
  border-left: 4px solid #dddddd;
  padding: 0 15px;
  color: #777777; }
  blockquote > :first-child {
    margin-top: 0; }
  blockquote > :last-child {
    margin-bottom: 0; }

table {
  padding: 0;border-collapse: collapse; }
  table tr {
    border-top: 1px solid #cccccc;
    background-color: white;
    margin: 0;
    padding: 0; }
    table tr:nth-child(2n) {
      background-color: #f8f8f8; }
    table tr th {
      font-weight: bold;
      border: 1px solid #cccccc;
      margin: 0;
      padding: 6px 13px; }
    table tr td {
      border: 1px solid #cccccc;
      margin: 0;
      padding: 6px 13px; }
    table tr th :first-child, table tr td :first-child {
      margin-top: 0; }
    table tr th :last-child, table tr td :last-child {
      margin-bottom: 0; }

img {
  max-width: 100%; }

span.frame {
  display: block;
  overflow: hidden; }
  span.frame > span {
    border: 1px solid #dddddd;
    display: block;
    float: left;
    overflow: hidden;
    margin: 13px 0 0;
    padding: 7px;
    width: auto; }
  span.frame span img {
    display: block;
    float: left; }
  span.frame span span {
    clear: both;
    color: #333333;
    display: block;
    padding: 5px 0 0; }
span.align-center {
  display: block;
  overflow: hidden;
  clear: both; }
  span.align-center > span {
    display: block;
    overflow: hidden;
    margin: 13px auto 0;
    text-align: center; }
  span.align-center span img {
    margin: 0 auto;
    text-align: center; }
span.align-right {
  display: block;
  overflow: hidden;
  clear: both; }
  span.align-right > span {
    display: block;
    overflow: hidden;
    margin: 13px 0 0;
    text-align: right; }
  span.align-right span img {
    margin: 0;
    text-align: right; }
span.float-left {
  display: block;
  margin-right: 13px;
  overflow: hidden;
  float: left; }
  span.float-left span {
    margin: 13px 0 0; }
span.float-right {
  display: block;
  margin-left: 13px;
  overflow: hidden;
  float: right; }
  span.float-right > span {
    display: block;
    overflow: hidden;
    margin: 13px auto 0;
    text-align: right; }

code, tt {
  margin: 0 2px;
  padding: 0 5px;
  white-space: nowrap;
  border: 1px solid #eaeaea;
  background-color: #f8f8f8;
  border-radius: 3px; }

pre code {
  margin: 0;
  padding: 0;
  white-space: pre;
  border: none;
  background: transparent; }

.highlight pre {
  background-color: #f8f8f8;
  border: 1px solid #cccccc;
  font-size: 13px;
  line-height: 19px;
  overflow: auto;
  padding: 6px 10px;
  border-radius: 3px; }

pre {
  background-color: #f8f8f8;
  border: 1px solid #cccccc;
  font-size: 13px;
  line-height: 19px;
  overflow: auto;
  padding: 6px 10px;
  border-radius: 3px; }
  pre code, pre tt {
    background-color: transparent;
    border: none; }

sup {
    font-size: 0.83em;
    vertical-align: super;
    line-height: 0;
}
* {
	-webkit-print-color-adjust: exact;
}
@media screen and (min-width: 914px) {
    body {
        width: 854px;
        margin:0 auto;
    }
}
@media print {
	table, pre {
		page-break-inside: avoid;
	}
	pre {
		word-wrap: break-word;
	}
}
</style>
<style type="text/css">
/**
 * prism.js default theme for JavaScript, CSS and HTML
 * Based on dabblet (http://dabblet.com)
 * @author Lea Verou
 */

code[class*="language-"],
pre[class*="language-"] {
	color: black;
	text-shadow: 0 1px white;
	font-family: Consolas, Monaco, 'Andale Mono', monospace;
	direction: ltr;
	text-align: left;
	white-space: pre;
	word-spacing: normal;
	word-break: normal;
	line-height: 1.5;

	-moz-tab-size: 4;
	-o-tab-size: 4;
	tab-size: 4;

	-webkit-hyphens: none;
	-moz-hyphens: none;
	-ms-hyphens: none;
	hyphens: none;
}

pre[class*="language-"]::-moz-selection, pre[class*="language-"] ::-moz-selection,
code[class*="language-"]::-moz-selection, code[class*="language-"] ::-moz-selection {
	text-shadow: none;
	background: #b3d4fc;
}

pre[class*="language-"]::selection, pre[class*="language-"] ::selection,
code[class*="language-"]::selection, code[class*="language-"] ::selection {
	text-shadow: none;
	background: #b3d4fc;
}

@media print {
	code[class*="language-"],
	pre[class*="language-"] {
		text-shadow: none;
	}
}

/* Code blocks */
pre[class*="language-"] {
	padding: 1em;
	margin: .5em 0;
	overflow: auto;
}

:not(pre) > code[class*="language-"],
pre[class*="language-"] {
	background: #f5f2f0;
}

/* Inline code */
:not(pre) > code[class*="language-"] {
	padding: .1em;
	border-radius: .3em;
}

.token.comment,
.token.prolog,
.token.doctype,
.token.cdata {
	color: slategray;
}

.token.punctuation {
	color: #999;
}

.namespace {
	opacity: .7;
}

.token.property,
.token.tag,
.token.boolean,
.token.number,
.token.constant,
.token.symbol,
.token.deleted {
	color: #905;
}

.token.selector,
.token.attr-name,
.token.string,
.token.char,
.token.builtin,
.token.inserted {
	color: #690;
}

.token.operator,
.token.entity,
.token.url,
.language-css .token.string,
.style .token.string {
	color: #a67f59;
	background: hsla(0, 0%, 100%, .5);
}

.token.atrule,
.token.attr-value,
.token.keyword {
	color: #07a;
}

.token.function {
	color: #DD4A68;
}

.token.regex,
.token.important,
.token.variable {
	color: #e90;
}

.token.important {
	font-weight: bold;
}

.token.entity {
	cursor: help;
}
</style>
</head>
<body>
<h3 id="toc_0">这是目前收集到的信息，我会更新的。</h3>

<p>我知道这些东西，尤其是相关的专业资料有点太多太深，我贴给你，是想尽快让你你可以和老公可以去了解，我也跟着看。如果有问题，你来问我，我去查。</p>

<p><strong>检索的关键词：</strong><br>
非小细胞肺癌， Afatinib(阿法替尼)， 基因检测</p>

<p><strong>对话：</strong><br>
“1.靶向药有几种，分别针对哪些类型的癌细胞？<br>
2.癌细胞是否会产生耐药性？<br>
3.服用前需要做哪些检查？”  </p>

<p>谈诤，遗传学分析师。</p>

<blockquote>
<p>我不是医生，只是在做肿瘤的基因检测，个人意见仅供参考。</p>

<ol>
<li>靶向药有很多，按来源可分为单抗和小分子化合物。按作用位点有target EGFR tyrosine kinase的gefitinib （Iressa，易瑞沙）和erlotinib （Tarceva, 特罗凯）， target ROS1， ALK, cMET的crizotinib, target BRAF的vemurafenib,dabrafenib。作用位点相同，但是肿瘤组织来源不同，用药有可能不同。比如vemurafenib and dabrafenib都可以用于BRAF突变的melanoma，但如果是BRAF突变的non small cell lung cancer, guideline推荐dabrafenib，不推荐vemurafenib.</li>
<li><p>耐药性非常普遍。靶向药的副作用一般比化疗放疗小，药物有效是病人的生活质量较好，但是往往几个月一年就会出现耐药性。但是现在也有不少新一代的靶向药针对的就是对老一代靶向药的耐药性。比如EGFR T790M的出现会导致对易瑞沙和特罗凯的耐药，而Afatinib， AZD9291针对的就是EGFR T790M引起的耐药。又比如ceritinib的推出针对的是对crizotinib的耐药。魔高一尺道高一丈，魔再高一些，会有新的道再高一些。</p></li>
<li><p>对于东亚女性，无吸烟史的肺癌往往都是由EGFR突变导致的。还需要检测KRAS mutation， ROS1, ALK translocation, cMET amplification. 当然有条件的话，可以做更多的基因，更全面的检查，有更多option。</p></li>
<li><p>如果不是遗传的突变，母婴传播的肺癌好像不大可能。</p></li>
</ol>

<p>再推荐一个网址：http://www.yuaigongwu.com
国内癌症病人的交流群，易瑞沙特罗凯不一定纳入了医保，可以去问问怎么买印度版的。
癌症到晚期大多很不好治，还是要早发现，早干预。希望癌症的早期筛查方法可以尽早成熟。</p>
</blockquote>

<p>余岚，哥伦比亚大学博士后，浙江大学分子生物学副教授</p>

<blockquote>
<p>&quot;2. 会, 3. 除了常规 做个基因检测吧&quot;</p>
</blockquote>

<p>刘赟，上海交大生命科学院分子遗传学副教授</p>

<blockquote>
<p>&quot;1，很多，小分子靶向药和抗体药太多种，络氨酸激酶通路最多，2，会，3，分子检测&quot;<br>
&quot;甲醛引起的应该是白血病。&quot;<br>
“争取入组<em>阿法替尼</em>实验组 <a href="http://wenku.baidu.com/link?url=1Wzn8T-DDfd822hlasQiRXEYYLha1GJ_HhnT9xpYvW99ftieVQHAjKKr95L0qRqDC6b1zuwtoJNpljZVOBRBFDmWRx-3_73u6WJaatmjw97">相关资料1</a>。”</p>
</blockquote>

<p>汪晓燕，苏州生物科技创投</p>

<blockquote>
<p>&quot;1、小分子靶向药，抗体药，2、绝对会，3、测基因突变&quot;<br>
“哪种肺癌？非小细胞肺癌的话测基因突变用易瑞沙<a href="http://wenku.baidu.com/link?url=1Wzn8T-DDfd822hlasQiRXEYYLha1GJ_HhnT9xpYvW99ftieVQHAjKKr95L0qRqDC6b1zuwtoJNpljZVOBRBFDmWRx-3_73u6WJaatmjw97">相关资料1</a>”<br>
“海德堡有个癌症治疗中心， 欧洲很多去海德堡” </p>
</blockquote>

<p>赵健, UCLA博士后<br>
提供了大部分资料链接。</p>

<blockquote>
<p>&quot;最好能参加临床实验&quot;</p>
</blockquote>

<p><strong>相关资料：</strong><br>
1. <a href="http://wenku.baidu.com/link?url=1Wzn8T-DDfd822hlasQiRXEYYLha1GJ_HhnT9xpYvW99ftieVQHAjKKr95L0qRqDC6b1zuwtoJNpljZVOBRBFDmWRx-3_73u6WJaatmjw97">Afatinib(阿法替尼)治疗非小细胞肺癌的研究进展</a> (<a href="https://dl.dropboxusercontent.com/u/3637996/mypage/targeted_therapy/Afatinib%28%E9%98%BF%E6%B3%95%E6%9B%BF%E5%B0%BC%29%E6%B2%BB%E7%96%97%E9%9D%9E%E5%B0%8F%E7%BB%86%E8%83%9E%E8%82%BA%E7%99%8C%E7%9A%84%E7%A0%94%E7%A9%B6%E8%BF%9B%E5%B1%95.pdf">下载pdf</a>)<br>
2. <a href="http://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=206682862&amp;idx=2&amp;sn=aaa213dc575a2094f7721116fa4ad991&amp;scene=1&amp;key=2f5eb01238e84f7e39694a387ef9dc68a63635fa1e65e023ac400d93c3c039de450f5425e93040111c7adb29a6079e5b&amp;ascene=0&amp;uin=MTI3OTExNQ%3D%3D&amp;devicetype=iMac+MacBookPro10%2C1+OSX+OSX+10.10.1+build(14B25)&amp;version=11000003&amp;pass_ticket=04qVBZTGbZM91kmv3IOtfqAu19O6KOXFk7IEn%2BAZ4kk%3D">EGFR 基因突变和 ALK 融合基因阳性 NSCLC 诊疗指南</a><br>
3. <a href="http://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=208084485&amp;idx=1&amp;sn=5fc597aa383002452fb02285306a9fe7&amp;scene=1&amp;key=2f5eb01238e84f7e9ac8cf2e8cbe7d0edc7043a34ea4565716fb38f9275bc14ddbcd58cdb65fd78f86e4161ba58e0717&amp;ascene=0&amp;uin=MTI3OTExNQ%3D%3D&amp;devicetype=iMac+MacBookPro10%2C1+OSX+OSX+10.10.1+build(14B25)&amp;version=11000003&amp;pass_ticket=04qVBZTGbZM91kmv3IOtfqAu19O6KOXFk7IEn%2BAZ4kk%3D">那些年，FDA批准过的实体肿瘤靶向药物</a><br>
4. <a href="http://m.biodiscover.com/news/industry/113434.html?from=timeline&amp;isappinstalled=0">2014年药物研发最热门靶点逐个述评</a><br>
5. <a href="http://mp.weixin.qq.com/s?__biz=MzA4MjM1NjQxNw==&amp;mid=202242762&amp;idx=1&amp;sn=db635a1154ef17313edf5cddbbbaa7a9&amp;key=2f5eb01238e84f7ed9c3b8e57bdd2353d4cdd8a0b5a9632552ff0aef02f8767f3e0b74c69b9f6d351d1150edf53753cd&amp;ascene=0&amp;uin=MTI3OTExNQ%3D%3D&amp;devicetype=iMac+MacBookPro10%2C1+OSX+OSX+10.10.1+build(14B25)&amp;version=11000003&amp;pass_ticket=04qVBZTGbZM91kmv3IOtfqAu19O6KOXFk7IEn%2BAZ4kk%3D">14种肿瘤抗体靶向药物，你都了解吗？</a><br>
6. <a href="http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-treating-targeted-therapies">Targeted therapies for non-small cell lung cancer</a><br>
7. <a href="http://www.cancer.gov/cancertopics/factsheet/Therapy/targeted">Targeted Cancer Therapies</a><br>
8. <a href="http://en.wikipedia.org/wiki/Targeted_therapy_of_lung_cancer">Wikipedia:Targeted therapy of lung cancer</a></p>

<script type="text/javascript">
self=typeof window!="undefined"?window:typeof WorkerGlobalScope!="undefined"&&self instanceof WorkerGlobalScope?self:{};var Prism=function(){var e=/\blang(?:uage)?-(?!\*)(\w+)\b/i,t=self.Prism={util:{encode:function(e){return e instanceof n?new n(e.type,t.util.encode(e.content),e.alias):t.util.type(e)==="Array"?e.map(t.util.encode):e.replace(/&/g,"&amp;").replace(/</g,"&lt;").replace(/\u00a0/g," ")},type:function(e){return Object.prototype.toString.call(e).match(/\[object (\w+)\]/)[1]},clone:function(e){var n=t.util.type(e);switch(n){case"Object":var r={};for(var i in e)e.hasOwnProperty(i)&&(r[i]=t.util.clone(e[i]));return r;case"Array":return e.slice()}return e}},languages:{extend:function(e,n){var r=t.util.clone(t.languages[e]);for(var i in n)r[i]=n[i];return r},insertBefore:function(e,n,r,i){i=i||t.languages;var s=i[e];if(arguments.length==2){r=arguments[1];for(var o in r)r.hasOwnProperty(o)&&(s[o]=r[o]);return s}var u={};for(var a in s)if(s.hasOwnProperty(a)){if(a==n)for(var o in r)r.hasOwnProperty(o)&&(u[o]=r[o]);u[a]=s[a]}t.languages.DFS(t.languages,function(t,n){n===i[e]&&t!=e&&(this[t]=u)});return i[e]=u},DFS:function(e,n,r){for(var i in e)if(e.hasOwnProperty(i)){n.call(e,i,e[i],r||i);t.util.type(e[i])==="Object"?t.languages.DFS(e[i],n):t.util.type(e[i])==="Array"&&t.languages.DFS(e[i],n,i)}}},highlightAll:function(e,n){var r=document.querySelectorAll('code[class*="language-"], [class*="language-"] code, code[class*="lang-"], [class*="lang-"] code');for(var i=0,s;s=r[i++];)t.highlightElement(s,e===!0,n)},highlightElement:function(r,i,s){var o,u,a=r;while(a&&!e.test(a.className))a=a.parentNode;if(a){o=(a.className.match(e)||[,""])[1];u=t.languages[o]}if(!u)return;r.className=r.className.replace(e,"").replace(/\s+/g," ")+" language-"+o;a=r.parentNode;/pre/i.test(a.nodeName)&&(a.className=a.className.replace(e,"").replace(/\s+/g," ")+" language-"+o);var f=r.textContent;if(!f)return;var l={element:r,language:o,grammar:u,code:f};t.hooks.run("before-highlight",l);if(i&&self.Worker){var c=new Worker(t.filename);c.onmessage=function(e){l.highlightedCode=n.stringify(JSON.parse(e.data),o);t.hooks.run("before-insert",l);l.element.innerHTML=l.highlightedCode;s&&s.call(l.element);t.hooks.run("after-highlight",l)};c.postMessage(JSON.stringify({language:l.language,code:l.code}))}else{l.highlightedCode=t.highlight(l.code,l.grammar,l.language);t.hooks.run("before-insert",l);l.element.innerHTML=l.highlightedCode;s&&s.call(r);t.hooks.run("after-highlight",l)}},highlight:function(e,r,i){var s=t.tokenize(e,r);return n.stringify(t.util.encode(s),i)},tokenize:function(e,n,r){var i=t.Token,s=[e],o=n.rest;if(o){for(var u in o)n[u]=o[u];delete n.rest}e:for(var u in n){if(!n.hasOwnProperty(u)||!n[u])continue;var a=n[u];a=t.util.type(a)==="Array"?a:[a];for(var f=0;f<a.length;++f){var l=a[f],c=l.inside,h=!!l.lookbehind,p=0,d=l.alias;l=l.pattern||l;for(var v=0;v<s.length;v++){var m=s[v];if(s.length>e.length)break e;if(m instanceof i)continue;l.lastIndex=0;var g=l.exec(m);if(g){h&&(p=g[1].length);var y=g.index-1+p,g=g[0].slice(p),b=g.length,w=y+b,E=m.slice(0,y+1),S=m.slice(w+1),x=[v,1];E&&x.push(E);var T=new i(u,c?t.tokenize(g,c):g,d);x.push(T);S&&x.push(S);Array.prototype.splice.apply(s,x)}}}}return s},hooks:{all:{},add:function(e,n){var r=t.hooks.all;r[e]=r[e]||[];r[e].push(n)},run:function(e,n){var r=t.hooks.all[e];if(!r||!r.length)return;for(var i=0,s;s=r[i++];)s(n)}}},n=t.Token=function(e,t,n){this.type=e;this.content=t;this.alias=n};n.stringify=function(e,r,i){if(typeof e=="string")return e;if(Object.prototype.toString.call(e)=="[object Array]")return e.map(function(t){return n.stringify(t,r,e)}).join("");var s={type:e.type,content:n.stringify(e.content,r,i),tag:"span",classes:["token",e.type],attributes:{},language:r,parent:i};s.type=="comment"&&(s.attributes.spellcheck="true");if(e.alias){var o=t.util.type(e.alias)==="Array"?e.alias:[e.alias];Array.prototype.push.apply(s.classes,o)}t.hooks.run("wrap",s);var u="";for(var a in s.attributes)u+=a+'="'+(s.attributes[a]||"")+'"';return"<"+s.tag+' class="'+s.classes.join(" ")+'" '+u+">"+s.content+"</"+s.tag+">"};if(!self.document){if(!self.addEventListener)return self.Prism;self.addEventListener("message",function(e){var n=JSON.parse(e.data),r=n.language,i=n.code;self.postMessage(JSON.stringify(t.util.encode(t.tokenize(i,t.languages[r]))));self.close()},!1);return self.Prism}var r=document.getElementsByTagName("script");r=r[r.length-1];if(r){t.filename=r.src;document.addEventListener&&!r.hasAttribute("data-manual")&&document.addEventListener("DOMContentLoaded",t.highlightAll)}return self.Prism}();typeof module!="undefined"&&module.exports&&(module.exports=Prism);
</script>
</body>

</html>
